Juniper pharmaceuticals inc (JNP)
Income statement / Quarterly
Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues
Product revenues

9,343

10,074

7,004

8,389

9,569

7,726

6,495

7,057

7,334

6,325

4,516

6,735

6,055

5,585

5,436

5,905

3,508

3,294

1,845

5,456

7,019

5,373

-

4,193

5,439

-

-

-

-

-

-

Product revenues from related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

167

-

-

-

-

-

1,426

-

-

-

-

-

-

-

Service revenues

5,717

5,450

4,786

4,597

4,387

3,521

3,101

3,337

3,374

3,253

3,259

3,218

2,714

2,460

1,804

2,378

2,110

2,478

-

644

-

-

-

-

-

-

-

-

-

-

-

License revenues

250

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalties

-

-

-

-

-

-

11,334

1,162

902

899

850

1,040

864

991

946

3,254

1,036

363

111

107

91

86

-

112

106

-

-

-

-

-

-

Royalties from related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

714

911

888

837

800

-

904

-

-

-

-

-

-

-

Other revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

31

31

57

-

34

34

-

-

-

-

-

-

Total revenues

15,310

15,524

11,790

12,986

13,956

11,247

20,930

11,556

11,610

10,477

8,625

10,993

9,633

9,036

8,186

11,537

6,654

7,016

6,163

7,126

7,978

6,316

-

6,673

8,230

-

-

-

-

-

-

Cost of product revenues

6,158

6,016

4,237

5,160

5,303

4,313

3,703

3,683

4,182

4,027

2,228

4,192

3,521

3,112

2,708

3,383

1,953

2,426

2,482

2,748

2,831

2,842

-

1,889

2,718

-

-

-

-

-

-

Cost of product revenues from related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,297

-

-

-

-

-

-

-

Cost of service revenues

2,959

3,010

2,799

2,559

2,347

2,243

2,068

2,022

2,285

2,323

2,185

2,361

2,049

1,766

1,740

1,717

1,916

1,846

-

491

-

-

-

-

-

-

-

-

-

-

-

Total cost of revenues

9,117

9,026

7,036

7,719

7,650

6,556

5,771

5,705

6,467

6,350

4,413

6,553

5,570

4,878

4,448

5,100

3,869

4,272

4,338

3,239

2,831

2,842

-

3,186

4,465

-

-

-

-

-

-

Gross profit

6,193

6,498

4,754

5,267

6,306

4,691

15,159

5,851

5,143

4,127

4,212

4,440

4,063

4,158

3,738

6,437

2,785

2,744

1,825

3,887

5,147

3,474

-

3,486

3,764

-

-

-

-

-

-

Operating expenses
Sales and marketing

563

419

553

517

410

379

349

259

379

272

308

338

282

321

373

467

467

401

-

79

-

-

-

-

-

-

-

-

-

-

-

Research and development

1,055

974

1,575

2,291

1,648

1,346

1,442

2,304

3,797

2,133

1,925

1,598

2,132

1,384

-

236

-

-

-

-

-

-

-

143

159

-

-

-

-

-

-

Acquisition-related expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

184

947

9

483

-

-

-

-

-

-

-

-

-

General and administrative

6,518

4,089

3,122

3,238

4,604

4,421

4,251

3,111

3,244

3,460

3,102

2,220

2,562

2,574

1,751

2,148

2,239

2,451

2,157

1,594

2,310

1,978

-

1,901

1,923

-

-

-

-

-

-

Restructuring charge

-

-

-

756

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

8,136

5,482

5,271

6,802

6,662

6,146

6,042

5,674

7,420

5,865

5,335

4,156

4,976

4,279

2,551

2,851

2,706

2,852

2,701

2,620

2,319

2,461

-

2,045

2,082

-

-

-

-

-

-

Loss from operations

-1,943

1,016

-517

-1,535

-356

-1,455

9,117

177

-2,277

-1,738

-1,123

284

-913

-121

1,187

3,586

79

-108

-876

1,267

2,828

1,013

-

1,440

1,682

-

-

-

-

-

-

Interest expense, net

-29

-45

-25

-47

-30

-28

-23

-24

-24

-26

-25

-27

-27

-27

-26

-29

-29

-34

-

1

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of common stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-1

-70

-309

-

-428

-

-

-

-

-

-

-

-

-

-

-

Interest (expense) income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43

53

-

35

63

-

-

-

-

-

-

Change in fair value of common stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-155

205

-

1,065

-205

-

-

-

-

-

-

Other income, net

758

-199

1,568

127

10

42

564

90

81

125

166

114

37

171

193

76

36

-3

43

25

-56

-26

-

-19

-8

-

-

-

-

-

-

Total non-operating income (expense)

729

-244

-

80

-20

14

-

66

57

99

-

87

10

144

-

48

77

272

-

454

-168

232

-

-

-

-

-

-

-

-

-

Loss before income taxes

-1,214

772

1,026

-1,455

-376

-1,441

9,658

243

-2,220

-1,639

-982

371

-903

23

-

3,634

156

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) Income before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

164

-

1,721

2,660

1,245

-

391

1,942

-

-

-

-

-

-

Income tax expense

300

0

-141

-45

0

0

44

-5

48

4

-6

3

3

5

583

-110

166

12

333

3

3

3

-

2

-

-

-

-

-

-

-

Net loss

-1,514

772

1,167

-1,410

-376

-1,441

9,614

248

-2,268

-1,643

-976

368

-906

18

770

3,744

-10

152

-876

1,718

2,657

1,242

2,631

388

1,942

4,954

4,417

18,314

-

-

-

Adjustments attributable to preferred stockholders

-

-

-

-

-452

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (loss) income available to common stockholders

-1,514

772

-

-

76

-1,448

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic net (loss) income per common share

-0.14

0.07

0.10

-0.13

0.01

-0.13

0.89

0.02

-0.21

-0.15

-0.09

0.03

-0.08

0.00

0.06

0.35

0.00

0.01

-0.08

0.15

0.24

0.11

-

0.04

0.02

-

-

-

-

-

-

Diluted net (loss) income per common share

-0.14

0.06

0.14

-0.13

-0.03

-0.13

0.89

0.02

-0.21

-0.15

-0.09

0.03

-0.08

0.00

0.06

0.35

-0.01

-0.01

-0.09

0.11

0.24

0.09

-

0.04

0.02

-

-

-

-

-

-

Basic weighted average common shares outstanding

11,103

10,943

10,846

10,844

10,803

10,803

10,803

10,799

10,789

10,789

10,815

10,771

10,758

10,752

10,739

10,749

10,741

11,739

12,055

11,138

10,927

10,916

-

10,916

87,305

-

-

-

-

-

-

Diluted weighted average common shares outstanding

11,103

12,287

10,695

10,844

10,954

10,803

10,926

11,060

10,789

10,789

10,358

11,009

10,758

10,971

10,750

10,758

10,756

11,764

11,649

11,293

11,077

11,073

-

11,067

88,483

-

-

-

-

-

-

Foreign currency translation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

-15

3

-

-

-

NET INCOME (LOSS)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,186

257

-4,227

Foreign currency translation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

12

-14

Unrealized gain (loss) on short term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

104

-43

0

0

0

-

COMPREHENSIVE INCOME

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,063

4,358

18,318

-1,185

269

-4,242